Search
Zai Lab Ltd
ZLABAdd to Watchlist
19.150USD
+0.150+0.79%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.12BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.79%
5 Days
+4.25%
1 Month
+12.05%
6 Months
+8.56%
Year to Date
+8.56%
1 Year
-45.55%
Key Figures
19.050Open
19.610High
686.16KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.62%Turnover Ratio
19.000Prev. Close
18.790Low
9.61MTurnover
LossP/E Static
2.96P/B
0.00%Div Yield TTM
-15.70%ROA
44.34052wk High
0.63Volume Ratio
-257.10MNet Profit
110.64MShares
-1.6151EPS TTM
0.81Beta
-24.19%ROE
15.96052wk Low
4.32%Amplitude
61.72%Gross Margin
2.12BMarket Cap
5.27Reward/Risk
2.05%Risk Rate
TradingKey Stock Score of Zai Lab Ltd
Currency: USD Updated: 2026-06-30Key Insights
Zai Lab Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 57 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 33.88.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Zai Lab Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Zai Lab Ltd Highlights
StrengthsRisks
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 72.52% year-on-year.
Undervalued
The company’s latest PE is -11.76, at a low 3-year percentile range.
Held by Ron Baron
Star Investor Ron Baron holds 1.67M shares of this stock.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
33.876
Target Price
+78.30%
Upside Space
Zai Lab Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Zai Lab Ltd Info
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Ticker SymbolZLAB
CompanyZai Lab Ltd
CEODu (Ying)
Websitehttps://www.zailaboratory.com/
Related Instruments
-0.64%
-0.05%
-2.95%
-0.23%
-2.41%
-1.64%
-0.22%
+1.75%
-0.29%
-0.79%
+0.26%
-2.00%
-2.10%
-2.41%
+1.68%
0.00%
+0.19%
-1.97%
+0.06%
-0.44%Popular Instruments
FAQs
What is the current price of Zai Lab Ltd (ZLAB)?
The current price of Zai Lab Ltd (ZLAB) is 19.15.
What is the symbol of Zai Lab Ltd?
The ticker symbol of Zai Lab Ltd is ZLAB.
What is the 52-week high of Zai Lab Ltd?
The 52-week high of Zai Lab Ltd is 44.34.
What is the 52-week low of Zai Lab Ltd?
The 52-week low of Zai Lab Ltd is 15.96.
What is the market capitalization of Zai Lab Ltd?
The market capitalization of Zai Lab Ltd is 2.12B.
Is Zai Lab Ltd (ZLAB) currently rated as Buy, Hold, or Sell?
According to analysts, Zai Lab Ltd (ZLAB) has an overall rating of Buy, with a price target of 33.88.
What is the Earnings Per Share (EPS TTM) of Zai Lab Ltd (ZLAB)?
The Earnings Per Share (EPS TTM) of Zai Lab Ltd (ZLAB) is -1.60.